Title Povezanost koncentracije limfopoetina strome timusa u serumu s fenotipom astme dječje dobi
Title (english) Correlation between serum levels of thymic stromal lymphopoietin and childhood asthma phenotype
Author Renata Vrsalović
Mentor Miroslav Harjaček (mentor)
Committee member Alenka Gagro (predsjednik povjerenstva)
Committee member Sanja Popović-Grle (član povjerenstva)
Committee member Irena Ivković-Jureković (član povjerenstva)
Granter University of Zagreb School of Medicine Zagreb
Defense date and country 2022, Croatia
Scientific / art field, discipline and subdiscipline BIOMEDICINE AND HEALTHCARE Public Health and Health Care Public Health
Universal decimal classification (UDC ) 614 - Public health and hygiene. Accident prevention
Abstract Uvod: Astma je kronična upalna bolest dišnih putova karakterizirana predominacijom
pomagačkih limfocita T2. Limfopoetin strome timusa (TSLP) je citokin odgovoran za
preusmjeravanje na T2 odgovor u astmi. -----
Cilj: Ispitati koncentraciju TSLP-a u serumu bolesnika s astmom i u zdravih ispitanika, te
ustvrditi povezanost koncentracije TSLP u serumu s kliničkim i laboratorijskim
karakteristikama naših bolesnika. -----
Ispitanici i metode: U istraživanje je uključeno 207 ispitanika s astmom i 100 zdravih ispitanika
dobi od 1 do 13 godina. Svim ispitanicima izmjerena je koncentracija TSLP u serumu metodom
ELISA koristeći Human TSLP ELISA Kit (abcam, ab155444), a u 23 ispitanika koncentracija TSLP
u serumu izmjerena je i u akutnoj egzacerbaciji astme. -----
Rezultati: Koncentracija TSLP-a u serumu statistički je značajno veća u djece s astmom u
usporedbi sa zdravom djecom (p < 0,005). Nije nađena statistički značajna razlika u vrijednosti
koncentracije TSLP-a u serumu između tri različita fenotipa astme (astme s alergijskom
senzibilizacijom, astme bez alergijske senzibilizacije i astme inducirane virusnim infekcijama),
niti između djece s dobro kontroliranom i nekontroliranom astmom (na osnovi upitnika u
djece starije od 4 godine, spirometrijskih mjerenja). Koncentracija TSLP-a u serumu nije dobar
pokazatelj plućne funkcije, niti je značajno povišena u akutnoj egzacerbaciji astme. Ni
protuupalna terapija niti težina bolesti ne utječu na koncentraciju TSLP-a u serumu. Nađena
je statistički značajna razlika između kvartilnih skupina TSLP-a ovisno o uhranjenosti (p < 0,05),
te je moguća uloga masnih stanica na koncentraciju TSLP-a u serumu. Mršavija djeca imaju
niže, a pretila djeca više vrijednosti TSLP-a u serumu. -----
Zaključak: Rezultati ovog istraživanja potvrdili su hipotezu da je serumska koncentracija TSLPa
u djece oboljele od astme značajno veća od koncentracije TSLP-a u zdrave djece, no
koncentracija TSLP u serumu nije dobar biomarker u rutinskoj dijagnostici jer nam ne pomaže
u razvrstavanju djece u različite fenotipove astme, ni u procjeni kontrole astme dječje dobi,
niti je dobar pokazatelj plućne funkcije. Ostaje otvoreno pitanje o povezanosti koncentracije
TSLP-a u serumu i astme u pretilih osoba.
Abstract (english) Introduction: Asthma is a chronic inflammatory disorder of the airways characterized by a
predominant Th2 response. Thymic stromal lymphopoietin (TSLP) has been considered to
switch on the T2 response in asthma. -----
Aim: To evaluate the serum levels of TSLP in children with asthma and healthy controls, and
to establish the correlation of serum TSLP with specific clinical and laboratory characteristics
of our patients. -----
Patients and methods: The study included 207 children with asthma and 100 healthy controls
aged 1 to 13 years. Serum levels of TSLP were measured in all children by enzyme-linked
immunosorbent assay (ELISA) using the Human TSLP ELISA Kit (abcam, ab155444). In 23
children with asthma, TSLP were measured in acute asthma exacerbations as well.
Results: Serum levels of TSLP were significantly higher in children with asthma compared to
healthy children (p<0,005). No statistically significant difference was found in serum levels of
TSLP between the three different asthma phenotypes (asthma with allergic sensitization,
asthma without allergic sensitization and virus induced asthma), nor between children with
well-controlled and uncontrolled asthma (based on asthma control test score in children older
than 4 years or spirometric measurements). Serum level of TSLP is not a good indicator of
pulmonary function, nor is it significantly elevated in acute asthma exacerbation. Antiinflammatory
therapy and disease severity do not affect serum levels of TSLP. A statistically
significant differences was found between the quartile groups of TSLP depending on body
mass index (p<0.05), and the role of adipose cells on serum levels of TSLP is possible. Slimmer
children have lower, while obese ones have higher serum TSLP values. -----
Conclusion: The results of this study confirmed the hypothesis that serum levels of TSLP in
children with asthma are significantly elevated than in healthy children, but serum TSLP is not
a good biomarker in routine diagnostics because it does not help with classifying children into
different asthma phenotypes, neither in the assessment of childhood asthma control, nor is it a good indicator of lung function. The question of correlation between serum levels of TSLP
and asthma in obese individuals remains open.
Keywords
TSLP
astma
djeca
fenotip
Keywords (english)
TSLP
asthma
children
phenotype
Language croatian
URN:NBN urn:nbn:hr:105:120792
Project Number: IP-2016-06-7556 Title: NOVI I ZAPOSTAVLJENI VIRUSNI UZROČNICI INFEKCIJA DIŠNOG SUSTAVA U VULNERABILNIM SKUPINAMA BOLESNIKA Acronym: RESPIVIRUS Leader: Sunčanica Ljubin Sternak Jurisdiction: Croatia Funder: HRZZ Funding stream: IP
Study programme Title: Biomedicine and Health Sciences Study programme type: university Study level: postgraduate Academic / professional title: doktor/doktorica znanosti, područje biomedicine i zdravstvo (doktor/doktorica znanosti, područje biomedicine i zdravstvo)
Type of resource Text
Extent 137 str.
File origin Born digital
Access conditions Open access
Terms of use
Public note Sumentor: Sabina Škrgat
Created on 2022-03-29 08:54:09